June 15, 2022
By:
Asa Waldstein
PTSD Claims Enforcement Increasing
Takeaway -
Find and remove high-risk “buzzwords”
FDA enforcement of PTSD claims is increasing.
This year there have been five PTSD-related warning letters, up from just three PTSD-related letters in all of 2021. This is an example of a high-risk “buzzword” to watch out for, and a great opportunity for companies to ensure this word is not lurking in any marketing.
Look for high-risk words in:
- Old social media posts.
- Blogs: Here is a post about best practices for reducing risks when writing blogs.
- Hashtags: Here is a video about this.
Here’s a post about removing high-risk “buzzwords”.
Most PTSD letters also mention CBD, meaning any company selling cannabinoids should especially ensure they are not using high-risk words.
Disclaimer: The educational information provided here is for informational purposes only. Contact an attorney for specific legal advice. Rule #1 in compliance is to ensure marketing is truthful and not misleading.
Written by
Asa Waldstein
Asa Waldstein is a 24-year veteran of the dietary supplement industry, with experience spanning manufacturing, marketing, and regulatory compliance. He is the principal of Apex Compliance, a software company dedicated to streamlining regulatory marketing compliance for the dietary supplement and natural products sectors. Asa also leads Supplement Advisory Group, a boutique consultancy focused on marketing risk analysis, labeling, and practical compliance strategies for websites and social media. Asa has helped oversee three FDA GMP inspections with no 483s and was honored with the 2023 AHPA Herbal Hero Award and the 2024 What's Up Supps Policy and Change Agent Award. He currently serves as Chair of the American Herbal Products Association’s (AHPA) Cannabis Committee, helping shape policy and industry best practices